- Challenges in the implementation of joint clinical evaluation of medicines (JCA)
- Opportunities and threats of the European JCA for member states
- HTA and Joint Medicines Evaluation under the Polish presidency
- The importance and changes in the evaluation of clinical trials
Joint clinical evaluation of medicines 2025
14 March 2025 • 14:30
-15:30 • ballroom A
Session translated simultaneously EN / PL
Online broadcast session
See the retransmission
Log in
Please log in via the e-mail address and the password used during registration or with the ID and the code received from the Organizer.